Option Care Health, Inc. (OPCH) P/E Ratio History
Deep ValueTrading at 17.3x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1998–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Option Care Health, Inc. (OPCH) trades at a price-to-earnings ratio of 17.3x, with a stock price of $21.99 and trailing twelve-month earnings per share of $1.30.
The current P/E is 44% below its 5-year average of 30.8x. Over the past five years, OPCH's P/E has ranged from a low of 19.0x to a high of 79.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, OPCH trades at a 22% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, OPCH trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OPCH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OPCH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
OPCH P/E vs Peers
Home-based care services peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 39.8 | 3.95Best | +18% | |
| $2B | 28.3 | - | +53% | |
| $125B | 70.7 | - | -62% | |
| $90B | 19.6Lowest | - | +49% | |
| $52B | 34.4 | - | +87%Best | |
| $53B | 34.1 | - | +6% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
OPCH Historical P/E Data (1998–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $26.92 | $1.29 | 20.9x | -59% |
| FY2025 Q4 | Dec 31 2025 | $31.86 | $1.28 | 24.9x | -51% |
| FY2025 Q3 | - | $27.76 | $1.26 | 22.0x | -57% |
| FY2025 Q2 | Jun 30 2025 | $32.48 | $1.25 | 26.0x | -49% |
| FY2025 Q1 | Mar 31 2025 | $34.95 | $1.24 | 28.2x | -45% |
| FY2024 Q4 | - | $23.20 | $1.22 | 19.0x | -63% |
| FY2024 Q3 | Sep 30 2024 | $31.30 | $1.19 | 26.3x | -49% |
| FY2024 Q2 | Jun 30 2024 | $27.70 | $1.19 | 23.3x | -54% |
| FY2024 Q1 | Mar 31 2024 | $33.54 | $1.52 | 22.1x | -57% |
| FY2023 Q4 | Dec 31 2023 | $33.69 | $1.47 | 22.9x | -55% |
| FY2023 Q3 | Sep 30 2023 | $32.35 | $1.41 | 22.9x | -55% |
| FY2023 Q2 | Jun 30 2023 | $32.49 | $1.31 | 24.8x | -51% |
| FY2023 Q1 | Mar 31 2023 | $31.77 | $0.87 | 36.5x | -29% |
| FY2022 Q4 | Dec 31 2022 | $30.09 | $0.83 | 36.3x | -29% |
| FY2022 Q3 | Sep 30 2022 | $31.47 | $0.98 | 32.1x | -37% |
| FY2022 Q2 | - | $27.79 | $0.97 | 28.6x | -44% |
| FY2022 Q1 | - | $28.56 | $0.96 | 29.8x | -42% |
| FY2021 Q4 | Dec 31 2021 | $28.44 | $0.77 | 36.7x | -28% |
| FY2021 Q3 | - | $24.26 | $0.46 | 52.3x | +2% |
| FY2021 Q2 | Jun 30 2021 | $21.87 | $0.27 | 79.8x | +56% |
| FY2021 Q1 | Mar 31 2021 | $17.74 | $0.05 | 349.9x | +584% |
| FY2013 Q1 | Mar 31 2013 | $50.84 | $4.26 | 11.9x | -77% |
| FY2012 Q4 | Dec 31 2012 | $43.08 | $4.63 | 9.3x | -82% |
| FY2012 Q3 | Sep 30 2012 | $36.44 | $4.64 | 7.9x | -85% |
| FY2012 Q2 | Jun 30 2012 | $29.72 | $5.49 | 5.4x | -89% |
| FY2012 Q1 | Mar 31 2012 | $27.16 | $0.16 | 169.8x | +232% |
| FY2011 Q4 | Dec 31 2011 | $21.84 | $0.56 | 39.0x | -24% |
| FY2010 Q3 | - | $20.64 | $3.69 | 5.6x | -89% |
| FY2010 Q2 | Jun 30 2010 | $20.96 | $4.09 | 5.1x | -90% |
| FY2010 Q1 | Mar 31 2010 | $31.96 | $4.29 | 7.4x | -85% |
| FY2009 Q4 | - | $33.44 | $5.31 | 6.3x | -88% |
| FY2008 Q3 | - | $11.92 | $0.53 | 22.5x | -56% |
| FY2008 Q2 | Jun 30 2008 | $10.36 | $0.53 | 19.5x | -62% |
| FY2008 Q1 | Mar 31 2008 | $27.04 | $0.41 | 66.0x | +29% |
| FY2007 Q4 | Dec 31 2007 | $30.92 | $0.32 | 96.6x | +89% |
| FY2005 Q3 | Sep 30 2005 | $26.00 | $0.13 | 200.0x | +291% |
| FY2005 Q2 | - | $24.00 | $0.37 | 64.9x | +27% |
| FY2005 Q1 | - | $24.12 | $1.11 | 21.7x | -58% |
| FY2004 Q4 | Dec 31 2004 | $25.44 | $1.27 | 20.0x | -61% |
| FY2004 Q3 | - | $23.04 | $1.25 | 18.4x | -64% |
| FY2004 Q2 | Jun 30 2004 | $34.80 | $1.17 | 29.7x | -42% |
| FY2004 Q1 | Mar 31 2004 | $30.44 | $1.45 | 21.0x | -59% |
| FY2003 Q4 | Dec 31 2003 | $28.12 | $1.65 | 17.0x | -67% |
| FY2003 Q3 | - | $30.00 | $2.24 | 13.4x | -74% |
| FY2003 Q2 | Jun 30 2003 | $26.08 | $2.76 | 9.4x | -82% |
| FY2003 Q1 | Mar 31 2003 | $29.68 | $2.88 | 10.3x | -80% |
| FY2002 Q4 | - | $23.20 | $3.16 | 7.3x | -86% |
| FY2002 Q3 | Sep 30 2002 | $37.80 | $3.00 | 12.6x | -75% |
| FY2002 Q2 | Jun 30 2002 | $48.36 | $3.00 | 16.1x | -68% |
| FY2002 Q1 | Mar 31 2002 | $66.00 | $2.84 | 23.2x | -55% |
| FY2001 Q4 | Dec 31 2001 | $71.20 | $2.64 | 27.0x | -47% |
| FY2001 Q3 | Sep 30 2001 | $42.00 | $1.30 | 32.3x | -37% |
| FY2001 Q2 | Jun 30 2001 | $24.00 | $0.58 | 41.4x | -19% |
| FY2001 Q1 | Mar 31 2001 | $10.13 | $0.22 | 46.0x | -10% |
| FY1999 Q3 | - | $8.50 | $0.01 | 850.0x | +1562% |
| FY1999 Q2 | Jun 30 1999 | $9.75 | $0.45 | 21.7x | -58% |
| FY1999 Q1 | Mar 31 1999 | $9.25 | $0.77 | 12.0x | -77% |
| FY1998 Q4 | - | $13.50 | $1.09 | 12.4x | -76% |
Average P/E for displayed period: 51.1x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OPCH — Frequently Asked Questions
Quick answers to the most common questions about buying OPCH stock.
What is OPCH's P/E ratio?
Option Care Health, Inc. (OPCH) trailing twelve-month P/E ratio is 17.3x, based on TTM diluted EPS of $1.30. The 5-year average P/E is 30.8x and the historical range spans 19.0x to 79.8x.
Is OPCH stock overvalued or undervalued?
OPCH trades at 17.3x P/E, below its 5-year average of 30.8x. At the 0th percentile of its historical range (19.0x–79.8x), the stock is priced at a discount to its own history.
Is OPCH stock expensive?
No, OPCH is not expensive on a historical basis. The current P/E of 17.3x is below the 5-year average of 30.8x and sits at the 0th percentile of its valuation range.
What is OPCH's historical P/E range?
Over the past 5 years, OPCH's P/E ratio has ranged from 19.0x to 79.8x, with a median of 26.3x and an average of 30.8x. The current P/E of 17.3x places the stock at the 0th percentile of this range. Full historical data spans 1998–2026.
How does OPCH's P/E compare to the S&P 500?
OPCH trades at 17.3x P/E versus the S&P 500 median of 24.4x. The 29% discount to the market suggests lower growth expectations or perceived higher risk.
How does OPCH's valuation compare to Healthcare peers?
Option Care Health, Inc. P/E of 17.3x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is OPCH's PEG ratio?
OPCH PEG ratio is N/A, based on a P/E of 17.3x and EPS growth of 3.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is OPCH's earnings yield?
OPCH earnings yield is 5.78%, the inverse of its 17.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.